These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment. Serpente M; Bonsi R; Scarpini E; Galimberti D Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039 [TBL] [Abstract][Full Text] [Related]
3. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease. Minter MR; Taylor JM; Crack PJ J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334 [TBL] [Abstract][Full Text] [Related]
4. Microglia in Alzheimer's disease: A multifaceted relationship. ElAli A; Rivest S Brain Behav Immun; 2016 Jul; 55():138-150. PubMed ID: 26254232 [TBL] [Abstract][Full Text] [Related]
5. Innate immunity in Alzheimer's disease: a complex affair. Guillot-Sestier MV; Town T CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):593-607. PubMed ID: 23574177 [TBL] [Abstract][Full Text] [Related]
6. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence. Eikelenboom P; Veerhuis R; van Exel E; Hoozemans JJ; Rozemuller AJ; van Gool WA Curr Alzheimer Res; 2011 Mar; 8(2):142-50. PubMed ID: 21345167 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint. Marx F; Blasko I; Grubeck-Loebenstein B Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867 [TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease. Šimić G; Španić E; Langer Horvat L; Hof PR Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331 [TBL] [Abstract][Full Text] [Related]
13. Role of the peripheral innate immune system in the development of Alzheimer's disease. Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160 [TBL] [Abstract][Full Text] [Related]
14. Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma. Shie FS; Nivison M; Hsu PC; Montine TJ Curr Med Chem; 2009; 16(6):643-51. PubMed ID: 19199928 [TBL] [Abstract][Full Text] [Related]
15. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. Fiala M; Cribbs DH; Rosenthal M; Bernard G J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824 [TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices. Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243 [TBL] [Abstract][Full Text] [Related]
18. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside. Fiala M CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):192-6. PubMed ID: 20205641 [TBL] [Abstract][Full Text] [Related]
19. Immune defects in Alzheimer's disease: new medications development. Cashman JR; Ghirmai S; Abel KJ; Fiala M BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S13. PubMed ID: 19090986 [TBL] [Abstract][Full Text] [Related]
20. A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease. Zamolodchikov D; Strickland S Thromb Res; 2016 May; 141 Suppl 2():S59-61. PubMed ID: 27207427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]